CRANBURY, N.J.--(BUSINESS WIRE)--Innophos Holdings, Inc. (NASDAQ:IPHS) announced today the appointment of Eugenia Erlij as Vice President, Marketing. Erlij will have responsibility for Innophos’ brand and marketing strategy with a focus on elevating the Company’s presence in the Food, Health, and Nutrition (FHN) markets. She will report to Sherry Duff, Chief Marketing and Technology Officer at Innophos.
With more than 24 years of industry experience, Erlij is an accomplished marketing leader with a track record of driving growth through strategic planning and execution. Erlij joins Innophos from Venn Growth Collective, a consulting firm that she co-founded to create data-driven growth strategies. Prior to that, she spent nine years at Solenis/Ashland Water Technologies, where she held roles of increasing responsibility, including Global Marketing Director and Commercial Director, Food & Beverage. Earlier in her career, Erlij was Director, Customer Marketing for L Brands and was a consultant in McKinsey & Company’s Mexico City and Hong Kong offices.
Erlij will be responsible for developing a robust and agile marketing organization that is strongly backed by science and technology. In addition, she will be highly engaged in new product development and in the Company’s M&A efforts.
“We are delighted to welcome Eugenia to the Innophos team,” said Duff. “Eugenia brings deep insight and proven strength in developing and employing successful marketing strategies. Her extensive experience will be a critical driver in continuing to transform the organization from product-driven to market-centric. She will work closely with our technology and sales functions to implement plans that will sustain our core business while growing our presence and capabilities in attractive markets. Investing in highly-experienced professionals like Eugenia reflects our commitment to excellence as we execute on our Vision 2022 strategy.”
“I am thrilled to join such a diverse and talented team,” said Erlij. “As the Company evolves, we need to aggressively promote our brand and continue to leverage science and technology to create greater value for our customers. It is an exciting opportunity and I look forward to contributing to Innophos’ transformation into an FHN market leader.”
Erlij received her MBA, Marketing from Columbia Business School, Columbia University, and her BA, History from the University of Chicago. She also completed graduate studies at The Johns Hopkins University School of Advanced International Studies in Nanjing China.
About the Company
Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral, enzyme and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. In 2017 Innophos acquired Novel Ingredients and NutraGenesis, further expanding its food, health and nutrition platform. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit www.innophos.com. 'IPHS-G'
Safe Harbor for Forward-Looking and Cautionary Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. As such, final results could differ from estimates or expectations due to risks and uncertainties, including but not limited to: incomplete or preliminary information; changes in government regulations and policies; continued acceptance of Innophos' products and services in the marketplace; competitive factors; technological changes; Innophos' dependence upon suppliers; and other risks. For any of these factors, Innophos claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, as amended.